Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMay 31, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 31, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 31, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 26, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 26, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 24, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 24, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 24, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 24, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 24, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 24, 2011View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMay 18, 2011View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMay 17, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2011View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-115

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information